- Research Tracker
- Supplement safety
- Magnesium
What public sources say about the safety of magnesium: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.
Interactions and safety, in NIH's words
Magnesium may interact with certain medications, such as oral bisphosphonates, tetracyclines, and quinolone antibiotics. In addition, some medications, including diuretics and proton pump inhibitors, can affect magnesium status.
Several types of medications have the potential to interact with magnesium supplements or affect magnesium status. A few examples are provided below. People who are taking these and other medications on a regular basis should discuss their magnesium intakes with their health care providers.
Magnesium-rich supplements or medications can decrease the absorption of oral bisphosphonates, such as alendronate (Fosamax), that are used to treat osteoporosis [61]. Taking magnesium-rich supplements or medications at least 2 hours before or after oral bisphosphonates can minimize this interaction [57].
Medicines covered in that section: Bisphosphonates, Antibiotics, Diuretics, Proton pump inhibitors.
Quoted from the “Interactions with Medications” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.
FDA adverse-event reports (CAERS)
Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “MAGNESIUM”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.
Combination products: 307 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 377 reports where a product is named for magnesium alone. This split is made from product names and can misfile some products. Most-reported products: Magnesium (29); Citracal Plus Magnesium (27); Citracal Calcium + D Slow Release 1200 (25); Phillips' Laxative Dietary Supplement (21); Slow-Mag (19); Citracal Calcium+ D Slow Release 1200 (16).
| Most reported reactions (single-ingredient products) | Reports |
|---|---|
| Diarrhoea | 46 |
| Nausea | 31 |
| Choking | 31 |
| Dyspnoea | 30 |
| Vomiting | 23 |
| Dizziness | 22 |
| Death | 22 |
| Headache | 19 |
| Hypersensitivity | 18 |
| Foreign body | 17 |
| Loss of consciousness | 16 |
| Pain | 14 |
Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (271), Hospitalization (86), Other Serious Outcome (55), Visited Emergency Room (51), Visited a Health Care Provider (45), Life Threatening (26), Death (22), Disability (16).
Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.
Registered trials
22 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.
- A Trial of Magnesium Dependent Tinnitus Completed Results posted
- Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD) Completed
- Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy Completed
- Magnesium, Stress and Fibromyalgia Completed
- Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia Completed
- Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied Wi Completed
- Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease Completed
- Magnesium and Vitamin D Combination for Post-COVID Syndrome Completed
- Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression Completed
- A Virtual Clinical Trial to Examine the Effect of Magnesium Choline Citrate on Cognitive Function and Anxiety in Healthy Adolescents and Adults Not yet recruiting
- Outcomes of a Higher vs. Lower Hemodialysate Magnesium Concentration (Dial-Mag) Active, not recruiting
- Exploring the Effects of Magnesium Ions on Peripheral Neuropathy, Serum Magnesium Ion Concentration,Sleep Quality, and Quality of Life in Patients With Colorectal Cancer Receiving Not yet recruiting
- Effectiveness of Oral Magnesium Supplementation in Fibromyalgia Patients Not Responding to Standard Treatment Recruiting
- Routine Magnesium Testing and Supplementation in Acute Heart Failure (MAG-HF) Not yet recruiting
- Protein and Magnesium in Ulcerative Colitis Status unknown
- Comparative Efficacy of Magnesium Sulfate Iontophoresis and Extracorporeal Shockwave Therapy on Chronic Mechanical Neck Pain Enrolling by invitation
- Magnesium Bisglycinate in Major Depressive Disorder Recruiting
- Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients Terminated
- Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease Status unknown
- Light Fasting Diet and Magnesium in Polycystic Ovary Syndrome (PCOS) Not yet recruiting